New registry aims to unlock secrets of rare adrenal cancer

This study is a registry that collects information from up to 1,000 people diagnosed with adrenocortical carcinoma, a rare cancer of the adrenal gland. The goal is to gather data on how the disease progresses and how different treatments work, so doctors can better understand the cancer and plan future studies. No new treatments are being tested; instead, the registry helps researchers learn from real-world patient experiences.